UPDATE: RBC Capital Downgrades PTC Therapeutics (PTCT) to Underperform

November 30, 2020 5:12 AM EST Send to a Friend
(Updated - November 30, 2020 6:10 AM EST)

(updating comment)RBC Capital analyst Brian Abrahams downgraded PTC Therapeutics (NASDAQ: PTCT) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login